ArticleDrugs - real world outcomes2026

Patient‑Reported Satisfaction in Relapsing-Remitting Multiple Sclerosis: Advantages of At‑Home Self‑Administered Subcutaneous Ofatumumab Versus Other High‑Efficacy Therapies.

Francesco Pastore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.